Pharmacy Website
    Clinic Website

    Intelligence » Amyotrophic Lateral Sclerosis » Last Week

    Subscribe to get latest posts via email or subscribe to a RSS feed.

    New Funding to Significantly Boost Cancer, ALS Research

    Thursday, June 21, 2018 -- UCR biomedical scientist receives two grants to continue his research aimed at finding therapeutics for cancer and ALS.

    New Technique Helps Uncover Changes in ALS Neurons

    Wednesday, June 20, 2018 -- Northwestern Medicine scientists used an innovative technique to measure electrical activity in ALS neurons, finding changes in excitability that indicated disease, according to a study published in Stem Cell Reports.

    [Articles] Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial

    Tuesday, June 19, 2018 -- Rasagiline was safe in patients with amyotrophic lateral sclerosis. There was no difference between groups in the primary outcome of survival, although post-hoc analysis suggested that rasagiline might modify disease progression in patients with an initial slope of Amyotrophic Lateral Sclerosis Functional Rating Scale Revised greater than 0·5 points per month at baseline. This should be confirmed in another clinical trial.